These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8082780)

  • 1. Functional properties of a heterozygous mutation (Arg1174-->Gln) in the tyrosine kinase domain of the insulin receptor from a type A insulin resistant patient.
    Moritz W; Froesch ER; Böni-Schnetzler M
    FEBS Lett; 1994 Sep; 351(2):276-80. PubMed ID: 8082780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor.
    Kishimoto M; Hashiramoto M; Yonezawa K; Shii K; Kazumi T; Kasuga M
    J Biol Chem; 1994 Apr; 269(15):11349-55. PubMed ID: 7512563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.
    Iwanishi M; Haruta T; Takata Y; Ishibashi O; Sasaoka T; Egawa K; Imamura T; Naitou K; Itazu T; Kobayashi M
    Diabetologia; 1993 May; 36(5):414-22. PubMed ID: 8390949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles.
    Kusari J; Takata Y; Hatada E; Freidenberg G; Kolterman O; Olefsky JM
    J Biol Chem; 1991 Mar; 266(8):5260-7. PubMed ID: 2002058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internalization of the constitutively active arginine 1152-->glutamine insulin receptor occurs independently of insulin at an accelerated rate.
    Formisano P; DeNovellis G; Miele C; Tripodi F; Caruso M; Palumbo G; Beguinot L; Beguinot F
    J Biol Chem; 1994 Jun; 269(23):16242-6. PubMed ID: 8206928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene.
    Cocozza S; Porcellini A; Riccardi G; Monticelli A; Condorelli G; Ferrara A; Pianese L; Miele C; Capaldo B; Beguinot F
    Diabetes; 1992 Apr; 41(4):521-6. PubMed ID: 1607076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ala1048-->Asp mutation in the kinase domain of insulin receptor causes defective kinase activity and insulin resistance.
    Haruta T; Takata Y; Iwanishi M; Maegawa H; Imamura T; Egawa K; Itazu T; Kobayashi M
    Diabetes; 1993 Dec; 42(12):1837-44. PubMed ID: 8243830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of compound heterozygous insulin receptor mutations in congenital muscle fibre type disproportion myopathy for the receptor kinase activation.
    Klein HH; Müller R; Vestergaard H; Pedersen O
    Diabetologia; 1999 Feb; 42(2):245-9. PubMed ID: 10064106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor.
    Taira M; Taira M; Hashimoto N; Shimada F; Suzuki Y; Kanatsuka A; Nakamura F; Ebina Y; Tatibana M; Makino H
    Science; 1989 Jul; 245(4913):63-6. PubMed ID: 2544997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance.
    Kadowaki T; Bevins CL; Cama A; Ojamaa K; Marcus-Samuels B; Kadowaki H; Beitz L; McKeon C; Taylor SI
    Science; 1988 May; 240(4853):787-90. PubMed ID: 2834824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action.
    Formisano P; Sohn KJ; Miele C; Di Finizio B; Petruzziello A; Riccardi G; Beguinot L; Beguinot F
    J Biol Chem; 1993 Mar; 268(7):5241-8. PubMed ID: 8383132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes.
    Rau H; Kocova M; O'Rahilly S; Whitehead JP
    Diabetes; 2000 Jul; 49(7):1264-8. PubMed ID: 10909987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defect in tyrosine kinase activity of the insulin receptor from a patient with insulin resistance and acanthosis nigricans.
    Yamamoto R; Shiba T; Tobe K; Shibasaki Y; Koshio O; Izumi T; Odawara M; Mikami Y; Matsuura N; Akanuma Y
    J Clin Endocrinol Metab; 1990 Apr; 70(4):869-78. PubMed ID: 2180980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional properties of a naturally occurring Trp1200----Ser1200 mutation of the insulin receptor.
    Moller DE; Yokota A; Ginsberg-Fellner F; Flier JS
    Mol Endocrinol; 1990 Aug; 4(8):1183-91. PubMed ID: 1963473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient.
    Grunberger G; Comi RJ; Carpentier JL; Podskalny JM; McElduff A; Taylor SI; Gorden P
    J Lab Clin Med; 1988 Jul; 112(1):122-32. PubMed ID: 3292678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of exon 17 and a missense mutation in exon 20 of the insulin receptor gene in two brothers with a novel syndrome of insulin resistance (congenital fiber-type disproportion myopathy).
    Vorwerk P; Christoffersen CT; Müller J; Vestergaard H; Pedersen O; De Meyts P
    Horm Res; 1999; 52(5):211-20. PubMed ID: 10844410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance.
    Sasaoka T; Shigeta Y; Takata Y; Sugibayashi M; Hisatomi A; Kobayashi M
    Diabetologia; 1989 Jun; 32(6):371-7. PubMed ID: 2668084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor.
    Odawara M; Kadowaki T; Yamamoto R; Shibasaki Y; Tobe K; Accili D; Bevins C; Mikami Y; Matsuura N; Akanuma Y
    Science; 1989 Jul; 245(4913):66-8. PubMed ID: 2544998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln1152 insulin receptor mutation.
    Petruzziello A; Formisano P; Miele C; Di Finizio B; Riccardi G; Ferrara A; Beguinot L; Beguinot F
    J Clin Endocrinol Metab; 1993 Aug; 77(2):409-12. PubMed ID: 8393885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin receptor Arg1131-->Gln: a novel mutation in the catalytic loop of insulin receptor observed in insulin resistant diabetes].
    Kasuga M; Kishimoto M; Hashiramoto M; Yonezawa K; Kazumi T; Hagino H; Shii K
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):968-71. PubMed ID: 1470163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.